Clinical Trial

Essential Amino Acid Supplementation Enhances Post-prandial Amino Acid Availability Following a Standard-protein Breakfast in Older Adults

Completed
View on ClinicalTrials.gov →
Summary
Healthy older adults and those who have acute and chronic conditions suffer from reduced protein intake and are at risk of developing both chronic and acute sarcopenia. Amino acid supplementation can provide appropriate conditions for muscle protein synthesis to occur. However, the exact amino acid ratio that may optimise this is currently unknown. The purpose of this crossover trial is to compare different amino acid gels and identify which results in the greatest concentration of plasma amino acids following a standardised breakfast. This will allow development of management strategies for healthy and diseased populations who suffer from reduced protein intake.
Trial Details
NCT Number NCT07754760
Lead Sponsor Leeds Beckett University
Conditions Older Adults Without Any Specific Clinical Condition
Enrollment 10 participants
Start Date 2022-06-17
Primary Completion 2022-12-09 (estimated)
Study Completion 2022-12-09 (estimated)
Updated on ClinicalTrials.gov 2026-08-10